Key facts
- This page summarizes Validae Health, L.P.'s Form 4 filing for Metsera, Inc. (MTSR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2025, 21:05.
Validae Health, L.P. - 11 Nov 2025 Form 4 Insider Report for Metsera, Inc. (MTSR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MTSR
- Reported as of
- 11 Nov 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Nov 2025, 21:05:03 UTC
- Prior SEC filing
- 30 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Cox, Managing Authorized Signatory of Validae
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Validae Health, L.P. filed Form 4 for Metsera, Inc. (MTSR) on 13 Nov 2025.
Change
- Previous filing in this sequence was filed on 30 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002051634
Primary reporting owner
Validae Health, L.P.
- Relationship
- 10%+ Owner
- Address
- C/O POPULATION HEALTH PARTNERS, L.P., 1200 MORRIS TURNPIKE, SUITE 300, SHORT HILLS
- Signature
- /s/ Christopher Cox, Managing Authorized Signatory of Validae
- Signature date
- 13 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MTSR
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -12,767,462
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Validae Health, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Validae Health, L.P. ("Validae") distributed 99% of the shares of common stock of Metsera Inc. (the "Company") that it owned to Population Health Partners, L.P. ("PHP LP"), a partnership that owns 99% of its limited partnership interests, and 1% to Population Health Partners GP, LLC ("PHP GP LLC"), its sole general partner and owner of 1% of its limited partnership interests. PHP GP LLC is the sole general partner of Validae and PHP LP, and PHP GP LLC may be deemed to beneficially own the shares of common stock of the Company held by Validae and by PHP LP. Christopher Whitten Bernard, Christopher T. Cox and Clive A. Meanwell are members of PHP GP LLC and may be deemed to share the power to direct the disposition and vote of the shares of common stock of the Company held by the Validae, PHP GP LLC, and PHP LP.
Footnote F2
(Continued from footnote 1) Each of PHP GP LLC, Christopher Whitten Bernard, Christopher T. Cox and Clive A. Meanwell disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that it is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.